skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 61,372  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Cardiovascular Disease remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Coronary Calcium Score and Cardiovascular Risk
Material Type:
Article
Add to My Research

Coronary Calcium Score and Cardiovascular Risk

Journal of the American College of Cardiology, 2018-07, Vol.72 (4), p.434-447 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 24, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.05.027 ;PMID: 30025580

Full text available

2
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Material Type:
Article
Add to My Research

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

The New England journal of medicine, 2023-12, Vol.389 (24), p.2221-2232 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2307563 ;PMID: 37952131

Full text available

3
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-09, Vol.377 (13), p.1228-1239 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1612917 ;PMID: 28910237

Full text available

4
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
Material Type:
Article
Add to My Research

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

The Lancet (British edition), 2018-10, Vol.392 (10155), p.1311-1320 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31652-0 ;PMID: 30293769

Full text available

5
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2019-01, Vol.380 (4), p.347-357 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1812389 ;PMID: 30415602

Full text available

6
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis
Material Type:
Article
Add to My Research

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis

JAMA : the journal of the American Medical Association, 2018-04, Vol.319 (15), p.1566 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2018.2525 ;PMID: 29677301

Digital Resources/Online E-Resources

7
Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
Material Type:
Article
Add to My Research

Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus

The New England journal of medicine, 2018-10, Vol.379 (16), p.1540-1550 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804989 ;PMID: 30146932

Full text available

8
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Material Type:
Article
Add to My Research

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Diabetes care, 2018-02, Vol.41 (2), p.356-363 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-1096 ;PMID: 29203583

Full text available

9
Polypill Strategy in Secondary Cardiovascular Prevention
Material Type:
Article
Add to My Research

Polypill Strategy in Secondary Cardiovascular Prevention

The New England journal of medicine, 2022-09, Vol.387 (11), p.967-977 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208275 ;PMID: 36018037

Full text available

10
Multimorbidity in Older Adults With Cardiovascular Disease
Material Type:
Article
Add to My Research

Multimorbidity in Older Adults With Cardiovascular Disease

Journal of the American College of Cardiology, 2018-05, Vol.71 (19), p.2149-2161 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. All rights reserved. ;Copyright Elsevier Limited May 15, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.03.022 ;PMID: 29747836

Full text available

11
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study
Material Type:
Article
Add to My Research

Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.344

2017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13077 ;PMID: 28771923

Digital Resources/Online E-Resources

12
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Material Type:
Article
Add to My Research

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

The New England journal of medicine, 2020-01, Vol.382 (3), p.244-255 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1905239 ;PMID: 31893580

Full text available

13
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
Material Type:
Article
Add to My Research

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

The New England journal of medicine, 2020-10, Vol.383 (14), p.1305-1316 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2019422 ;PMID: 32865375

Full text available

14
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The New England journal of medicine, 2016-11, Vol.375 (19), p.1834-1844 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1607141 ;PMID: 27633186

Full text available

15
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Material Type:
Article
Add to My Research

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

Gut, 2020-09, Vol.69 (9), p.1691-1705 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2020-320622 ;PMID: 32321858

Full text available

16
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Material Type:
Article
Add to My Research

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

The New England journal of medicine, 2018-11, Vol.379 (22), p.2097-2107 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801174 ;PMID: 30403574

Full text available

17
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Material Type:
Article
Add to My Research

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet (British edition), 2019-01, Vol.393 (10166), p.31-39 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32590-X ;PMID: 30424892

Full text available

18
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
Material Type:
Article
Add to My Research

Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial

The Lancet (British edition), 2022-05, Vol.399 (10338), p.1876-1885 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00122-2 ;PMID: 35525255

Full text available

19
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review
Material Type:
Article
Add to My Research

Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review

Value in health, 2018-07, Vol.21 (7), p.881 [Peer Reviewed Journal]

Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. ;EISSN: 1524-4733 ;DOI: 10.1016/j.jval.2017.12.019 ;PMID: 30005761

Digital Resources/Online E-Resources

20
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1519-1529 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32261-X ;PMID: 30291013

Full text available

Results 1 - 20 of 61,372  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

New Records 

  1. New From Last Month  (238)
  2. New From Last 3 Month  (1,196)
  3. More options open sub menu

Subject 

  1. Science & Technology  (38,720)
  2. Life Sciences & Biomedicine  (34,829)
  3. Humans  (22,366)
  4. Diabetes  (16,976)
  5. Mortality  (16,390)
  6. Coronary Vessels  (15,352)
  7. Male  (13,816)
  8. Female  (13,522)
  9. Hypertension  (13,413)
  10. Risk Factors  (13,197)
  11. Hospitals  (13,141)
  12. Heart  (12,214)
  13. Heart Attacks  (11,356)
  14. Middle Aged  (10,970)
  15. Heart Failure  (10,730)
  16. Cardiovascular System & Cardiology  (10,682)
  17. Cardiology  (10,510)
  18. Cardiac & Cardiovascular Systems  (10,125)
  19. More options open sub menu

Language 

  1. English  (61,317)
  2. Japanese  (2,458)
  3. Portuguese  (184)
  4. Turkish  (84)
  5. Norwegian  (55)
  6. French  (47)
  7. Chinese  (34)
  8. German  (25)
  9. Polish  (15)
  10. Spanish  (13)
  11. Urdu  (5)
  12. Italian  (5)
  13. Russian  (3)
  14. Arabic  (1)
  15. Korean  (1)
  16. Dutch  (1)
  17. Bulgarian  (1)
  18. Slovenian  (1)
  19. Hindi  (1)
  20. Swedish  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait